WHO is spearheading the project of blood availability, accessibility, and safety globally for last several decades. WBDD is celebrated as public health campaign every year. Regulatory systems play a key role in assuring the quality, safety, and efficacy of medical products including blood products. Various tools have been used across the globe to access quality, safety, and efficacy of medical products. WHO has developed a global benchmarking tool (GBT)to harmonize and unify all previously used assessment tools and mechanisms. The benchmarking has been introduced for blood products too. The GBT+ blood has been published in November 2019. The GBT+ blood ensures policy coherence and reduces the unnecessary burden of benchmarking, costs and duplications for Member States.
To introduce and describe the use of the GBT + blood for benchmarking of national regulatory systems in the area of blood products (including whole blood, blood components and plasma derived medicinal products) the Blood, Blood products and products of human origin (BTT-HPS) and Regulation and Prequalification department (RPQ) are jointly planning to hold a webinar on “Introduction to the Global Benchmarking Tool Plus Blood (GBT+ Blood)” on 19 April 2021. Two sessions are being organized: a morning session from 09:00 to 11:00 CET and an afternoon session from 16:00 to 18:00 CET. This tool will significantly benefit all the blood establishments and blood regulators in assessing their Blood Regulatory Systems. The webinar will be open to all.